Phibro Animal Health | PAHC - 债务

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.47B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	债务	更改		日
Align Technology	USD 116.04M		1.6M	2026-03
ANI Pharmaceuticals	USD 617.04M		3.28M	2025-12
Aurora Cannabis	CAD 23.86M		76.48M	2026-03
Bristol-Myers Squibb	USD 46.43B		711M	2026-03
Canopy Growth	CAD 278.71M		19.38M	2026-03
Corcept Therapeutics	USD 9.64M		3.53M	2026-03
Eli Lilly	USD 42.5B		3.6M	2025-12
Henry Schein	USD 3.75B		313M	2026-03
Idexx Laboratories	USD 1.11B		129.39M	2026-03
Knight Therapeutics	CAD 77.91M		28.33M	2025-12
Merck	USD 49.34B		7.97B	2025-12
Nektar Therapeutics	USD 0		0	2022-06
Pacira	USD 367.66M		4.53M	2026-03
Phibro Animal Health	USD 474.17M		730K	2024-09
Prestige Brands	USD 1.08B		38.27M	2025-12
Supernus Pharmaceuticals	USD 40.98M		1.23M	2025-12
Zoetis	USD 9.24B		1.96B	2025-12